Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-07
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 59
MetricValuePeriodScopeSource row
Revenue¥1.81T2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥620.0bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥2.90T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.26T2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥728.5bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income−¥160.6bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income−¥27.0bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥71.4bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥10.9bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax−¥160.0bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥56.2bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥231m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥94.8bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax−¥32.0bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)−¥109.8bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥33.4bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥60.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥20.8bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income−¥164.9bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income−¥57.9bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income−¥46.9bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥41.7bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income−¥31.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥4.22Tat 2023-12-31Cons.Assets IFRS
Total assets¥4.17Tat 2023-03-31Cons.Assets IFRS
Total assets¥4.55Tat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.77Tat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥2.68Tat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.45Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥1.49Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.80Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.16Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.17Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.31Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥276.2bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥305.8bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥499.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥135.0bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥111.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥100.3bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥77.8bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥19.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥1.7bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥161.1bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥178.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥13.0bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-67.132023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-20.442023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥4.272022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥36.892022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-12.692022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥4.272022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥36.882022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
Equity ratio27.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.8%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 124
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥111.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-10-01 → 2023-12-31¥35.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥50.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-10-01 → 2023-12-31¥15.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥61.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-10-01 → 2023-12-31¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥8.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-10-01 → 2023-12-31¥4.0bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥81.0bn
Reconciling Itemsreconcilingrevenue2023-10-01 → 2023-12-31−¥25.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥81.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-10-01 → 2023-12-31−¥25.0bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥9.5bn
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2023-12-31−¥1.6bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue2023-04-01 → 2023-12-31¥238.1bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue2023-10-01 → 2023-12-31¥78.3bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2023-04-01 → 2023-12-31¥225.3bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2023-10-01 → 2023-12-31¥75.4bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥12.8bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥2.9bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2023-04-01 → 2023-12-31¥9.4bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2023-10-01 → 2023-12-31¥2.9bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2023-04-01 → 2023-12-31¥600.8bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2023-10-01 → 2023-12-31¥207.8bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2023-04-01 → 2023-12-31¥596.7bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2023-10-01 → 2023-12-31¥206.4bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥4.2bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥1.4bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥62.0bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2023-10-01 → 2023-12-31−¥17.6bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2023-04-01 → 2023-12-31¥369.4bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2023-10-01 → 2023-12-31¥126.3bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2023-04-01 → 2023-12-31¥367.0bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2023-10-01 → 2023-12-31¥125.8bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥2.4bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥521m
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2023-04-01 → 2023-12-31−¥1.4bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2023-10-01 → 2023-12-31¥6.2bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue2023-04-01 → 2023-12-31¥311.4bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue2023-10-01 → 2023-12-31¥107.5bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2023-04-01 → 2023-12-31¥311.1bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2023-10-01 → 2023-12-31¥107.4bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥331m
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥111m
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2023-04-01 → 2023-12-31¥36.8bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2023-10-01 → 2023-12-31¥19.0bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue2023-04-01 → 2023-12-31¥256.4bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue2023-10-01 → 2023-12-31¥89.5bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue external2023-04-01 → 2023-12-31¥256.4bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue external2023-10-01 → 2023-12-31¥89.5bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥2m
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue intersegment2023-10-01 → 2023-12-31¥1m
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentsegment profit2023-04-01 → 2023-12-31−¥95.6bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentsegment profit2023-10-01 → 2023-12-31−¥30.1bn
—segment totalrevenue2023-04-01 → 2023-12-31¥1.78T
—segment totalrevenue2023-10-01 → 2023-12-31¥609.3bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥1.76T
—segment totalrevenue external2023-10-01 → 2023-12-31¥604.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥19.6bn
—segment totalrevenue intersegment2023-10-01 → 2023-12-31¥4.9bn
—segment totalsegment profit2023-04-01 → 2023-12-31−¥112.8bn
—segment totalsegment profit2023-10-01 → 2023-12-31−¥19.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥128.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-10-01 → 2022-12-31¥48.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥64.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-10-01 → 2022-12-31¥26.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥63.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-10-01 → 2022-12-31¥21.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥7.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-10-01 → 2022-12-31¥5.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥85.5bn
Reconciling Itemsreconcilingrevenue2022-10-01 → 2022-12-31−¥28.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥85.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2022-12-31−¥28.0bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥14.4bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2022-12-31−¥2.8bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥270.7bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-10-01 → 2022-12-31¥87.0bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥257.1bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-10-01 → 2022-12-31¥83.6bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥13.6bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥3.4bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥16.9bn
jpcrp040300-q3r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-10-01 → 2022-12-31¥3.4bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-12-31¥680.1bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-10-01 → 2022-12-31¥209.8bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-12-31¥675.5bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-10-01 → 2022-12-31¥208.2bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥4.6bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥1.6bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-12-31−¥2.0bn
jpcrp040300-q3r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-10-01 → 2022-12-31−¥25.3bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-12-31¥442.3bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-10-01 → 2022-12-31¥146.4bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-12-31¥439.2bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-10-01 → 2022-12-31¥145.3bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥3.1bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-12-31¥47.2bn
jpcrp040300-q3r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-10-01 → 2022-12-31¥10.9bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-12-31¥338.9bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-10-01 → 2022-12-31¥116.5bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-12-31¥338.6bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-10-01 → 2022-12-31¥116.4bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥350m
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥116m
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-12-31¥43.7bn
jpcrp040300-q3r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-10-01 → 2022-12-31¥17.3bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-12-31¥482.5bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue2022-10-01 → 2022-12-31¥148.1bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-12-31¥482.5bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue external2022-10-01 → 2022-12-31¥148.0bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥14m
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-10-01 → 2022-12-31¥7m
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-12-31¥43.1bn
jpcrp040300-q3r_E00752-000Medical Productsreportable segmentsegment profit2022-10-01 → 2022-12-31¥17.9bn
—segment totalrevenue2022-04-01 → 2022-12-31¥2.21T
—segment totalrevenue2022-10-01 → 2022-12-31¥707.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥2.19T
—segment totalrevenue external2022-10-01 → 2022-12-31¥701.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥21.7bn
—segment totalrevenue intersegment2022-10-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥148.9bn
—segment totalsegment profit2022-10-01 → 2022-12-31¥24.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,072
ItemContextValueUnit
Independent auditors report consolidated (text)FilingDateInstantText · Plus
Audit firm1 consolidatedFilingDateInstant
Original text (Japanese)有限責任 あずさ監査法人
Cpa1 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)中  嶋     歩
Cpa2 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)富  田  亮  平
Cpa3 audit firm1 consolidatedFilingDateInstant
Original text (Japanese)渡  辺  直  人
Number of submissionFilingDateInstant1
Revenue IFRS (5-year summary)Prior1YTDDuration2257045000000JPY
Revenue IFRS (5-year summary)CurrentYTDDuration1806869000000JPY
Revenue IFRS (5-year summary)Prior1YearDuration2895283000000JPY
Revenue IFRS (5-year summary)Prior1QuarterDuration728482000000JPY
Revenue IFRS (5-year summary)CurrentQuarterDuration619994000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YTDDuration94772000000JPY
Profit loss before tax IFRS (5-year summary)CurrentYTDDuration-159953000000JPY
Profit loss before tax IFRS (5-year summary)Prior1YearDuration231000000JPY
Profit loss IFRS (5-year summary)Prior1YTDDuration41698000000JPY
Profit loss IFRS (5-year summary)CurrentYTDDuration-164946000000JPY
Profit loss IFRS (5-year summary)Prior1YearDuration-46865000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration60310000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration-109778000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1YearDuration6987000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)Prior1QuarterDuration-20753000000JPY
Profit loss attributable to owners of parent IFRS (5-year summary)CurrentQuarterDuration-33432000000JPY
Comprehensive income IFRS (5-year summary)Prior1YTDDuration150236000000JPY
Comprehensive income IFRS (5-year summary)CurrentYTDDuration-13058000000JPY
Comprehensive income IFRS (5-year summary)Prior1YearDuration65627000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YTDDuration135050000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)CurrentYTDDuration10526000000JPY
Comprehensive income attributable to owners of parent IFRS (5-year summary)Prior1YearDuration84077000000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1QuarterInstant1310894000000JPY
Equity attributable to owners of parent IFRS (5-year summary)CurrentQuarterInstant1162268000000JPY
Equity attributable to owners of parent IFRS (5-year summary)Prior1YearInstant1171192000000JPY
Total assets IFRS (5-year summary)Prior1QuarterInstant4550636000000JPY
Total assets IFRS (5-year summary)CurrentQuarterInstant4219651000000JPY
Total assets IFRS (5-year summary)Prior1YearInstant4165503000000JPY
Basic earnings loss per share IFRS (5-year summary)Prior1YTDDuration36.89
Basic earnings loss per share IFRS (5-year summary)CurrentYTDDuration-67.13
Basic earnings loss per share IFRS (5-year summary)Prior1YearDuration4.27
Basic earnings loss per share IFRS (5-year summary)Prior1QuarterDuration-12.69
Basic earnings loss per share IFRS (5-year summary)CurrentQuarterDuration-20.44
Diluted earnings loss per share IFRS (5-year summary)Prior1YTDDuration36.88
Diluted earnings loss per share IFRS (5-year summary)CurrentYTDDuration-
Diluted earnings loss per share IFRS (5-year summary)Prior1YearDuration4.27
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1QuarterInstant0.288
Ratio of owners equity to gross assets IFRS (5-year summary)CurrentQuarterInstant0.275
Ratio of owners equity to gross assets IFRS (5-year summary)Prior1YearInstant0.281
Cash flows from used in operating activities IFRS (5-year summary)Prior1YTDDuration100330000000JPY
Cash flows from used in operating activities IFRS (5-year summary)CurrentYTDDuration-134964000000JPY
Cash flows from used in operating activities IFRS (5-year summary)Prior1YearDuration111621000000JPY
Cash flows from used in investing activities IFRS (5-year summary)Prior1YTDDuration1677000000JPY
Cash flows from used in investing activities IFRS (5-year summary)CurrentYTDDuration-77807000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass